Compare SPGI & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SPGI | MDT |
|---|---|---|
| Founded | 1860 | 1949 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 151.3B | 125.3B |
| IPO Year | N/A | N/A |
| Metric | SPGI | MDT |
|---|---|---|
| Price | $526.42 | $97.20 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 18 |
| Target Price | ★ $609.31 | $108.44 |
| AVG Volume (30 Days) | 1.5M | ★ 5.7M |
| Earning Date | 02-10-2026 | 11-18-2025 |
| Dividend Yield | 0.73% | ★ 2.92% |
| EPS Growth | ★ 21.42 | 12.98 |
| EPS | ★ 13.74 | 3.69 |
| Revenue | $15,012,000,000.00 | ★ $34,758,000,000.00 |
| Revenue This Year | $9.85 | $8.61 |
| Revenue Next Year | $7.32 | $5.86 |
| P/E Ratio | $38.26 | ★ $26.36 |
| Revenue Growth | ★ 9.04 | 5.34 |
| 52 Week Low | $427.14 | $79.29 |
| 52 Week High | $579.05 | $106.33 |
| Indicator | SPGI | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 70.18 | 41.60 |
| Support Level | $495.00 | $96.89 |
| Resistance Level | $515.87 | $99.26 |
| Average True Range (ATR) | 7.72 | 1.36 |
| MACD | 3.09 | -0.59 |
| Stochastic Oscillator | 95.13 | 6.61 |
S&P Global provides data and benchmarks to capital and commodity market participants. Its ratings business is the largest credit rating agency in the world and S&P's largest segment by profitability. S&P's largest segment by revenue is market intelligence, which provides desktop, data and advisory solutions, enterprise solutions, and credit/risk solutions mostly in the financial-services industry. S&P's other segments include commodity insights (Platts and other data), mobility (Carfax), and indexes.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.